The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

Journal of the Neurological Sciences

Volumn 202, Issue 1-2, 2002, Pages 13-23

  Minagar, Alireza ^a   Shapshak, Paul ^b   Fujimura, Robert ^b   Ownby, Ray ^b   Heyes, Melvin ^c   Eisdorfer, Carl ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alzheimer disease; Astrocytes; HIV associated dementia; Macrophage microglia; Multiple sclerosis

Indexed keywords

AMYLOID BETA PROTEIN; ANTIGEN; CHEMOKINE; CYTOKINE; LIPID; NEUROTOXIN; NEUROTROPHIN; NITRIC OXIDE; OLIGOPEPTIDE;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CELL DAMAGE; CELL FUNCTION; CELL STRUCTURE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; DEMENTIA; DEMYELINATION; DISEASE COURSE; EFFECTOR CELL; GRAY MATTER; HIV ASSOCIATED DEMENTIA; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPETENT CELL; MACROPHAGE; MICROGLIA; MICROORGANISM; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; ANTIGEN PRESENTATION; ASTROCYTES; CELL DIFFERENTIATION; HUMANS; MACROPHAGES; MICROGLIA; MULTIPLE SCLEROSIS;

EID: 0037110424     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00207-1     Document Type: Review

References (150)

1. Benveniste E.N. Role of macrophage/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:1997;165-173.
2. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
3. Gordon S. The macrophage. Bioessays. 17:1995;977-986.
4. Gehrmann J., Matsumoto Y., Kreutzenberg G.W. Microglia: intrinsic immunoeffector cell of the brain. Brain Res. Rev. 20:1995;269-287.
5. Walker D.G., Kim S.U., McGeer P.L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40:1995;478-493.
6. Shrikant P., Weber E., Jilling T., Benveniste E.N. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6. J. Immunol. 155:1995;1489-1501.
7. Panek R.B., Benveniste E.N. Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α and TGF-β J. Immunol. 154:1995;2846-2854.
8. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
9. Suzumura A., Mezitis S.G.E., Gonatas N.K., Silberberg D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by γ-interferon. J. Neuroimmunol. 15:1987;263-278.
10. Williams K., Ulvestad E., Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
11. De Simone R., Giampaolo A., Giometto B., Gallo P., Levi G., Peschle C.et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropath. Exp. Neurol. 187:1995;175-187.
12. Williams K., Bar-Or A., Ulvestad E., Olivier A., Antel J.P., Yong V.W. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J. Neuropathol. Exp. Neurol. 51:1992;538-549.
13. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307:1984;273-276.
14. Merrill J.E., Jonakait G.M. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J. 9:1995;611-618.
15. Kraus E., Schneider-Schaulis S., Miyasaka M., Tamatani T., Sedgwick J. Augmentation of major histocompatibility complex class I and ICAM-I expression on glial cells following measles virus infection: evidence for the role of type-1 interferon. Eur. J. Biochem. 22:1992;175-182.
16. Janssen R.S., Nwanyanwu O.C., Selik R.M., Stehr-Green J.K. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 42:1992;1472-1476.
17. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19:1986;517-524.
18. Maher J., Choudhri S., Halliday W., Power C., Nath A. AIDS dementia complex with generalized myoclonus. Mov. Disord. 12:1997;593-597.
19. Mirsattari S.M., Berry M.E., Holden J.K., Ni W., Nath A., Power C. Paroxysmal dyskinesias in patients with HIV infection. Neurology. 52:1999;109-114.
20. Levy R.M., Breseden D.E., Rosenblum M.L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 62:1985;474-495.
21. McArthur J.C., Hoover D.R., Bacellar H.et al. Dementia in AIDA patients: incidence and risk factors. Neurology. 43:1993;2245-2252.
22. Resnick L., Berger J.R., Shapshak P., Tourtellotte W.W. Early penetration of the blood-brain-barrier by HIV. Neurology. 38:1988;9-14.
23. Achim C., Masliah E., Heyes M.P., Sarnacki P.G.et al. Macrophage activation factors in the brains of AIDS patients. J. Neuro-AIDS. 1:1996;1-16.
24. Michaels J., Sharer L.R., Epstein L.G. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic. Rev. 1:1988;71-104.
25. Goudsmit J., de Wolf F., Paul D.A., Epstein L.G.et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 2:1986;177-180.
26. Ho D.D., Rota T.R., Schooley R.T., Kaplan J.C.et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 12(313):1985;1493-1497.
27. Masliah E., Nianfeng G., Achim C.L., DeTeresa R., Wiley C.A. Patterns of neurodegeneration in HIV encephalitis. J. Neuro-AIDS. 1:1996;161-173.
28. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeskpour G.H., Yungblut M.et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
29. Sharer L.R. Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51:1992;3-11.
30. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;755-762.
31. Gendleman E.H., Orenstein J.M., Baca L.M., WeiSeries B., Burger H., Kalter D.C.et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS. 3:1989;475-495.
32. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L.et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 42:1992;1739-1763.
33. Dickson D.W., Mattiace L.A., Kure K., Hutchins K., Layman W.D., Brosnan C.F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64:1991;135-156.
34. Wesselingh S.L., Power C., Glass J.D., Tyor W.R., McArthur J.C., Farber J.M.et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:1993;576-582.
35. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L.et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
36. Conant K., Garzino Demo A., Nath A., McArthur J.C., Halliday W., Power C.et al. Induction of monocytes chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3117-3121.
37. Nuovo G.J., Alfieri M.L. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2:1996;358-366.
38. Vitkovic L., da Cunha A., Tyor W.R. Cytokine expression and pathogenesis in AIDS brain. Price R.W., Perry S.W. HIV, AIDS and the Brain. 1994;203-222 Raven Press, New York.
39. Nottet H.S., Persidsky Y., Sasseville V.G., Nukuna A.N., Bock P., Zhai Q.H.et al. Mechanisms of the transendothelial migration of HIV-1 infected monocytes into brain. J. Immunol. 156:1996;1284-1295.
40. Boven L.A., Gomes L., Hery C., Gary F., Verhoef J., Portegies P.et al. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J. Immunol. 162:1999;4319-4327.
41. Johnson R.T., McArthur J.C., Narayan O. The neurobiology of human immunodeficiency virus infections. FASEB J. 2:1988;2970-2981.
42. Snyder S. Nitric oxide: first in a new class of neurotransmitters? Science. 257:1992;494-496.
43. Kuljis R.O., Shapshak P., Rodriguez de la Vega P., Fujimara R., Petito C.K. Increased density of neurons containing NADPH diaphorase/nitric oxide synthase in the cerebral cortex of patients with HIV-1 infection and drug abuse. J. Neuro-AIDS. 2002;. (in press).
44. Heyes M.P., Brew B.J., Martin A.et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
45. Heyes M.O., Brew B.J., Satio K.et al. Inter-relationships between quinolinic acid, neuroactive kynurenis, neopterin and ∃2-microglobulin in cerebrospinal fluid and serum of HIV-1 infected patients. J. Neuroimmunol. 40:1992;71-80.
46. Heyes M.P., Mefford I.N., Quearry B.J., Dedhia M., Lackner A. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. Ann. Neurol. 27:1990;666-675.
47. Heyes M.P., Rubinow D., Lane C., Markey S.P. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann. Neurol. 26:1989;275-277.
48. Heyes M.P., Saito K., Crowley S.et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Ann. Neurol. 115:1992;1249-1273.
49. Nath A., Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54:1998;19-33.
50. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K.et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
51. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical structures. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6368-6371.
52. Wilt S.G., Milward E., Zhou J.M., Nagasato K., Patton H.et al. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 38:1995;483.
53. Wesselingh S.L., Takahashi K., Glass J.D., McArthur J.C., Griffin J.W., Griffin D.E. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74:1997;1-8.
54. Adamson D.C., Wildemann B., Sasaki M., Glass J.D., McArthur J.C.et al. HIV-1 gp41. Science. 13:1996;1917-1921.
55. Nottet H.S., Bar D.R., van Hassel H., Verhoef J., Boven L.A. Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis. J. Leukoc. Biol. 62:1997;107-116.
56. Byrne G.I., Lehmann L.K., Kirschbaum J.G., Borden E.C.et al. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interferon Res. 6:1986;389-396.
57. Fuchs D., Shearer G.W., Boswell R.N.et al. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS. 5:1991;209-212.
58. Werner E.R., Bitterlich G., Fuchs D.et al. Human macrophages degrade tryptophan upon induction by interferon gamma. Life Sci. 41:1987;273-280.
59. Schmidtmayerova H., Nottet H.S., Nuovo G., Raabe T., Flanagan C.R., Dubrovsky L.et al. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. U. S. A. 93:1996;700-704.
60. Nuovo G.J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144:1994;659-666.
61. Saito Y., Sharer L.R., Epstein L.G.et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 44:1994;474-487.
62. Tornatore C., Chandra R., Berger J.R., Major E.O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
63. Takahashi K., Wesselingh S.L., Griffin D.E., McArthur J.C.et al. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:1996;511-705.
64. Bagasra O., Lavi E., Bobroski L.et al. Cellular reservoirs of HIV-1 infection in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS. 10:1996;573-585.
65. Ranki A., Nyberg M., Ovod V.et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS. 9:1995;1001-1008.
66. Kleinschmidt A., Neumann M., Moller C., Erfle V., Brack Werner R. Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNS. Res. Virol. 145:1994;147-153.
67. Conant K., Ma M., Nath A., Major E.O. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1996;1384-1389.
68. Zidovetzki R., Wang J.L., Chen P., Jeyaseelan R., Hofman F. Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase. AIDS Res. Hum. Retrovir. 14:1998;825-833.
69. Chen P., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272:1997;22385-22388.
70. Wyss-Coray T., Masliah E., Toggas S.M., Rockenstein E.M., Brooker M.J., Lee H.S.et al. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp 120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798.
71. Lannuzel A., Barnier J.V., Hery C., Huynh V.T., Guibert B., Gary F.et al. Human immunodeficiency virus type 1 and its coat protein gp 120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol. 42:1997;847-856.
72. Fiala M., Rhodes R.H., Shapshak P.et al. Regulation of HIV-1 infection in astrocytes: expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. J. Neurovirol. 2:1996;158-166.
73. Vitkovic L., Wood G.P., Major E.O., Fauci A.S. Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. AIDS Res. Hum. Retrovir. 7:1991;723-727.
74. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system: I. Expression and recognition. Trends Neurosci. 18:1995;83-88.
75. Fiala M., Looney D.J., Stins M.et al. TNF-α opens a paracellular route for HIV-1 invasion across the blood brain barrier. Mol. Med. 3:1997;553-564.
76. Dreyer E.B., Lipton S.A. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7:1995;2502-2507.
77. Fine S.M., Angel R.A., Perry S.W.et al. Tumor necrosis factor alpha-inhibits glutamate uptake by primary human astrocytes-implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271:1996;15303-15306.
78. Nottet H.S.L.M., Jett M., Flanagan C.R. A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1 infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:1995;3567-3581.
79. Mallat M., Chamak B. Brain macrophages: neurotoxic or neurotrophic effector cells? Leukoc. Biol. 56:1994;416-422.
80. Boven L.A., Middel J., Portegies P., Verhoef J., Jansen G.H., Nottet H.S. Overexpression of nerve growth factor and basic fibroblast factor in AIDS dementia complex. J. Neuroimmunol. 3690:1999;154-162.
81. Pechan P.A., Chowdhury K., Siefert W. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. NeuroReport. 3:1992;469-472.
82. Ballabriga J., Pozas E., Planas A.M., Ferrer I. BFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia. Brain Res. 752:1997;315-318.
83. Mucke L., Eddleston M. Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J. 7:1993;1226-1232.
84. Rosenberg P.A. Accumulation of extracellular glutamate and neuronal death in astrocyte-poor cortical cultures exposed to glutamine. Glia. 4:1991;91-100.
85. Selkoe D.J. Alzheimer's disease: genotypes, phenotype, and treatments. Science. 275:1997;630-631.
86. Terry R.D., Masliah E., Salmon D.P., Butters N.et al. Physical basis of cognitive alteration in Alzheimer's disease: synaptic loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
87. Cummings J.L., Vinters H.V., Cole G.M., Khachaturian Z.S. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology. 51:1998;S2-S17.
88. Lue L.F., Kuo Y.M., Roher A.E., Brachova L.et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155:1999;853-862.
89. Gendelman H.E., Folks D.G. Innate and acquired immunity in neurodegenerative disorders. J. Leukoc. Biol. 65:1999;407-408.
90. Cotter R.L., Burke W.J., Thomas V.S., Potter J.F., Zheng J., Gendelman H.E. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukoc. Biol. 65:1999;416-427.
91. Cotter R.L., Burke W.J., Thomas V.S., Potter J.F., Zheng J., Gendelman H.E. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukoc. Biol. 65:1999;416-427.
92. Selkoe D.J. Notch and presenilins in vertebrates and invertebrates: implications for neuronal development and degeneration. Curr. Opin. Neurobiol. 10:2000;50-57.
93. Giulian D., Haverkamp L.J., Li J., Karshin W.L., Yu J., Tom D.et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer's brain. Neurochem. Int. 27:1995;119-137.
94. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
95. McGeer E.G., McGeer P.L. The role of the immune system in neurodegenerative disorders. Mov. Disord. 12:1997;855-858.
96. McGeer P.L., McGeer E.G., Kawamata T., Yamada T., Akiyama H. Reactions of the immune system in chronic degenerative neurological diseases. Can. J. Neurol. Sci. 18:1991;376-379.
97. Rozemuller J.M., Eikelenboom P., Stam F.C. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch. B: Cell Pathol. Incl. Mol. Pathol. 51:1986;247-254.
98. Rozemuller J.M., Eikelenboom P., Pals S.T., Stam F.C. Microglial cells around amyloid plaques in Alzheimer's disease express leukocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101:1989;288-292.
99. Wisniewski H.M., Wegiel J., Wang K.C., Kujawa M., Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16:1989;535-542.
100. Lorton D., Kocsis J.M., King L., Madden K., Brunden K.R. Beta-amyloid induces increased release of interleukin-1beta from lipopolysaccharide-activated human monocytes. J. Neuroimmunol. 67:1996;21-29.
101. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha. Brain Res. 747:1997;114-121.
102. Klegeris A., McGeer P.L. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49:1997;229-235.
103. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun. 199:1994;984-991.
104. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:1997;2284-2294.
105. Elkabes S., DiCicco Bloom E.M., Black I.B. Brain microglia/macrophages express neurotrophines that selectively regulate microglial proliferation and function. J. Neurosci. 16:1996;2508-2521.
106. Giulian D., Haverkamp L.J., Yu J.H., Karshin W., Tom D., Li J.et al. Specific domains of beta-amyloid from Alzheimer's plaque elicit neuron killing in human microglia. J. Neurosci. 16:1996;6021-6037.
107. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. Beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:1998;4451-4460.
108. Combs C.K., Johnson D.E., Cannady S.B., Lehman T.M., Landreth G.E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19:1999;928-939.
109. Yanker B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
110. Benna J.E., Dang P.M., Gaudry M., Fay M.et al. Phosphorylation of the respiratory burst oxidase subunit p67 (phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J. Biol. Chem. 272:1997;17204-17208.
111. Bonaiuto C., McDonald P.P., Rossi F., Cassatella M.A. Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia. J. Neuroimmunol. 77:1997;699-707.
112. Heese K., Hock C., Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70:1998;699-707.
113. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr.et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
114. Yan S.D., Chen X., Fu J., Zhu H.et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
115. Du Yan S., Zhu H., Fu J., Yan S.F., Roher A.et al. Amyloid-beta peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5296-5301.
116. Hu J., Van Eldik L.J. Glial-derived proteins activate cultured astrocytes and enhance Aβ-induced glial activation. Brain Res. 842:1999;46-54.
117. Song W., Zhu X.Z. Up-regulation of LPS-induced iNOS activity in dibutyryl cyclic AMP-differentiated rat astrocytes. Chung-Kuo Yao Li Hsueh Pao. 19:1998;462-466.
118. Tanaka C., Kamata H., Takeshita H., Yagisawa H., Hirata H. Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. Biochem. Biophys. Res. Commun. 232:1997;568-573.
119. Lieb K., Fiebich B.L., Schaller H., Berger M., Bauer J. Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67:1996;2039-2044.
120. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5795-5800.
121. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206.
122. Weldon D.T., Maggio J.E., Mantyh P.W. New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics. 52(Suppl. 2):1997;S13-S16.
123. McMillan M., Kong L.Y., Sawin S.M., Wilson B.et al. Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem. Biophys. Res. Commun. 215:1995;572-577.
124. Vincent V.A., Tilders F.J., Van Dam A.M. Inhibition of endotoxins-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta. Glia. 19:1997;190-198.
125. DeWitt V.A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149:1998;329-340.
126. Xiao B.-G., Link H. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies? Trends Immunol. Today. 20:1999;477-479.
127. De Simone R., Giampaolo A., Giometto B., Gallo P.et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:1995;175-178.
128. Cannella B., Raine C.S. The adhesion molecules and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
129. Gerritse K., Laman J.D., Noelle R.J., Aruffi A.et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2499-2504.
130. Williams K., Ulvestad E., Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
131. Chao C.C., Hu S., Sheng W.S., Peterson P.K. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci. 17:1995;97-105.
132. Merill J.E., Ignarro L.J., Sherman M.P., Melinek J.et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
133. Williams K. Jr., Ulvestad E., Cragg L., Blain M.et al. Induction of primary T cell responses by human glial cells. J. Neurosci. Res. 36:1993;382-390.
134. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307:1984;273-276.
135. Wong G.H., Bartlett I., Clark-Lewis F., Battye F.et al. Inducible expression of H-2 and Ia antigens on brain cells. Nature. 310:1984;688-691.
136. Weber F., Meinl E., Aloisi C., Nevinny-Stickel C.et al. Human astrocytes are only partially competent antigen presenting cells: possible implications for lesion development in multiple sclerosis. Brain. 117:1994;59-69.
137. Meinl E., Aloisi F., Ertl B., Weber F.et al. Multiple sclerosis: immunomodulatory effects of human astrocytes on T cells. Brain. 117:1994;1232-1323.
138. McCallum K., Esiri M.M., Tourtellotte W.W., Booss J. T cell subsets in multiple sclerosis. Brain. 110:1987;1297-1308.
139. Sanders V., Conrad A.J., Tourtellotte W.W. On classification of post-mortem multiple sclerosis plaques for neuroscientists. J. Neuroimmunol. 46:1993;207-216.
140. Prineas J.W., Wright R.G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38:1978;409-421.
141. Dalakas M., Wright R.G., Prineas J.W. Nature of the reversible white matter lesion in multiple sclerosis. Brain. 103:1980;515-524.
142. Walsh M.J., Murray J.M. Dual implication of 29,39-cyclic nucleotide 39 phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 101:1998;1923-1931.
143. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 23:1993;547-549.
144. Ford A.L., Foulcher E., Lemckert F.A., Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. Exp. Med. 184:1996;1737-1745.
145. Oh L.Y., Yong V.W. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia. 17:1996;237-253.
146. Awatsuji H., Furukawa Y., Hirota M., Murakami Y., Nii S., Furukawa S.et al. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J. Neurosci. Res. 34(5):1993;539-545.
147. Pender M.P., Rist M.J. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia. 36:Nov. 2001;137-144.
148. von Zahn J., Moller T., Kettenmann H., Nolte C. Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. NeuroReport. 8:1997;3851-3856.
149. Aloisi F., Penna G., Cerase J., Menendez I., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. Immunology. 159:1997;1604-1612.
150. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.